Literature DB >> 29895542

Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.

Aires Martins1, Alvaro Gonçalves1, Teresa Almeida1, Alberto Midões1.   

Abstract

Carcinoembryonic antigen (CEA) is still the most widely used tumour marker for gastrointestinal cancer. CEA was originally thought to be a specific marker for colorectal cancer, but it turned out to be a non-specific marker for further studies. CEA levels can be elevated in breast, lung and liver cancers, among others, including medullary thyroid cancer. The authors report a case of a 73-year-old woman who had a right hemicolectomy for an ascending colon adenocarcinoma and showed a persistent elevation in the CEA marker during follow-up. After several imaging tests, recurrence of the colon cancer was not found, but the presence of thyroid nodules had been detected. The diagnosis of a medullary thyroid carcinoma was made after the finding of a high value of calcitonin. The patient had a total thyroidectomy with resection of the central and lateral lymph nodes. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  endocrine cancer; head and neck surgery; screening (oncology); thyroid disease

Mesh:

Substances:

Year:  2018        PMID: 29895542      PMCID: PMC6011426          DOI: 10.1136/bcr-2017-223233

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 2.  Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer.

Authors:  Julien Hadoux; Martin Schlumberger
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2017-04-28       Impact factor: 4.690

  2 in total
  1 in total

Review 1.  A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC).

Authors:  Ioannis Passos; Elisavet Stefanidou; Soultana Meditskou-Eythymiadou; Maria Mironidou-Tzouveleki; Vasiliki Manaki; Vasiliki Magra; Styliani Laskou; Stylianos Mantalovas; Stelian Pantea; Isaak Kesisoglou; Konstantinos Sapalidis
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.